Innovation Pharmaceuticals Inc (IPIX)

[Fletch]

A reminder of views from Cellceutix,
Fletch

http://cellceutix.com/cellceutix-provides-corporate-update/#sthash.rN2Jx7uP.dpbs
NASDAQ Uplisting

Our NASDAQ application is in process. We made our selections and now received confirmation of acceptance of positions for new members to the Company’s Board of Directors and committees required to move to the NASDAQ exchange. This information has been prepared in the form of an 8-K filing for submission to the Securities and Exchange Commission (SEC) and is currently being reviewed by our SEC counsel. Under guidance of our legal counsel, we will be publicly releasing this information simultaneously with the 8-K submission.

“There are many exciting developments ongoing at Cellceutix, both at the corporate level and from a drug development perspective,” commented Leo Ehrlich, Chief Executive Officer at Cellceutix. ”We have always held that the best approach to build shareholder value is to conduct multiple projects concurrently. We are executing efficiently at this business model, targeting large markets with novel drugs, while running a lean operation. In a relatively short period of time, we have grown exponentially and will soon have several Phase 2 trials and a Phase 3 study happening as we stand in the best financial position in the Company’s history.”

Sign-up for Cellceutix email alerts is available at

- See more at: http://cellceutix.com/cellceutix-provides-corporate-update/#sthash.rN2Jx7uP.dpuf